{"data":{"id":"us-in/ic-25-26-14-11","jurisdiction":"us-in","citation":"IC 25-26-14-11","heading":"\"Wholesale distribution\"","body":"Sec. 11. As used in this chapter, \"wholesale distribution\" means to distribute legend drugs to persons other than a consumer or patient. The term does not include:\n(1) a sale or transfer between a division, a subsidiary, a parent, an affiliated, or a related company under the common ownership and control of a corporate entity;\n(2) the purchase or acquisition by a hospital or other health care entity that is a member of a group purchasing organization of a drug for the hospital's or health care entity's own use from the group purchasing organization or from other hospitals or health care entities that are members of the organization;\n(3) the sale or transfer of a drug by a charitable organization described in Section 501(c)(3) of the Internal Revenue Code, to:\n(A) a nonprofit affiliate of the organization; or\n(B) a nonprofit entity described in Section 501(c)(3) of the Internal Revenue Code that is not affiliated with the organization;\nto the extent otherwise permitted by law;\n(4) the sale of a drug among hospitals or other health care entities that are under common control;\n(5) the sale of a drug for emergency medical reasons, including transfers of legend drugs by a retail pharmacy to another retail pharmacy to alleviate a temporary shortage, if the gross dollar value of the transfers does not exceed five percent (5%) of the total legend drug sales revenue of either the transferor or transferee pharmacy during any twelve (12) consecutive month period;\n(6) the sale of a drug or the dispensing of a drug pursuant to a prescription;\n(7) the distribution of drug samples by manufacturers' representatives or distributors' representatives;\n(8) the sale of blood and blood components intended for transfusion;\n(9) the sale of a drug by a retail pharmacy to a practitioner (as defined in IC 25-26-13-2) for office use, if the gross dollar value of the transfers does not exceed five percent (5%) of the retail pharmacy's total legend drug sales during any twelve (12) consecutive months;\n(10) the sale of a drug by a retail pharmacy that is ending its business and liquidating its inventory to another retail pharmacy;\n(11) drug returns by a hospital, health care entity, or charitable institution conducted under 21 CFR 203.23;\n(12) the sale of minimal quantities of drugs by retail pharmacies to licensed practitioners for office use;\n(13) the distribution of prescription drugs by the original manufacturer of the finished form of the prescription drug or the distribution of the co-licensed products by a partner of the original manufacturer of the finished form of the prescription drug;\n(14) drug returns that meet criteria established by rules adopted by the board;\n(15) the sale of a drug for research or clinical trial purposes, provided the seller is authorized by the federal Food and Drug Administration to sell the drug for research or clinical trial purposes; or\n(16) the donation, acceptance, distribution, or dispensing of a legend drug as part of the prescription drug donation repository program under IC 25-26-26.","path":["TITLE 25. PROFESSIONS AND OCCUPATIONS","ARTICLE 26. PHARMACISTS, PHARMACIES, DRUG STORES","Chapter 14. Wholesale Legend Drug Distributors and Third Party Logistics Providers"],"source_url":"https://iga.in.gov/ic/2026/Title_25.html#25-26-14-11","current_through":"2026","vintage":"2026","retrieved_at":"2026-10-06T20:43:28Z","sha256":"b21a79942b4241a4a8dd74d0f08c77a04a1788cd181b0b569e6e1299e94994f4","source_id":"us-in","stale":false,"prev":"us-in/ic-25-26-14-10.5","next":"us-in/ic-25-26-14-12"},"notice":"GroundRules: Original legal text. Not legal advice."}